How Are Rakesh Jhunjhunwala’s Favourite Stocks Performing Two Years After His Death?

Two years ago today (August 14th), ace investor Rakesh Jhunjhunwala passed away at 62 due to a cardiac arrest. His remarkable legacy lives on, as does the admiration of countless followers. Jhunjhunwala, a self-made stock market trader and entrepreneur, transformed an initial investment of just Rs 5,000 into billions. According to Trendlyne data, his family’s portfolio was worth $6 billion (Rs 50,563 crore) at an exchange rate of 83.90 per dollar, up from Rs 33,942.63 crore in the July-September 2022 quarter. His family's top holdings include Titan Company Ltd, Star Health and Allied Insurance Company Ltd, Tata Motors Ltd, Concord Biotech Ltd, Metro Brands Ltd, and NCC Ltd. Notably, NCC delivered a 393% return, trading at Rs 318.40 on Tuesday compared to Rs 64.50 in August 2022. Canara Bank, a PSU stock, saw a 131% return, trading at Rs 106.75 versus Rs 46.19 in August 2022. Titan Company Ltd, Jhunjhunwala’s largest stock bet, gained 37%, with the RJ family holding shares worth approximately Rs 16,000 crore. Meanwhile, Star Health and Allied Insurance Company, his second-largest holding, decreased by 16.76%. Federal Bank Ltd and Fortis Healthcare Ltd each surged by 83%, Metro Brands Ltd rose by 48%, and CRISIL increased by 39%. Concord Biotech went public on August 18, 2023. Business Today TV's Sakshi Batra speaks with top market analyst CA Rudra Murthy about Rakesh Jhunjhunwala's lasting legacy and its impact on India's stock market.